You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Single-Dose Cefazolin Prophylaxis for Toxic Shock Syndrome

MICHAEL D. POOLE, MD, PHD
Tallahassee, Fla

Arch Otolaryngol Head Neck Surg. 1989;115(2):248.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—I read with concern the design and conclusions of the article by Jacobsen et al.1 Briefly, they concluded that antibiotic prophylaxis is not indicated for the prevention of toxic shock syndrome from nasal surgery, since a single dose of cefazolin failed to eliminate Staphylococcus in nasal carriers. The study reinforces the substantial body of preexisting evidence that a single dose of antibiotic therapy, used for surgical prophylaxis, does not result in significant elimination of skin, respiratory, or colonic flora. Staphylococci are particularly hard to eradicate in the nares, with eradication consistently achieved only by using rifampin (preferably along with another anti-Staphylococcus drug).2,3

Nonetheless, the efficacy of antibiotic prophylaxis in preventing wound infections in "clean-contaminated" cases cannot be denied. This appears to work because the antibiotics administered during the time of surgery provide levels within the wound, including microhematomas and devasculized tissue, such that . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.